Lv1
40 积分 2026-02-04 加入
Analysis of phase II and phase III clinical trial terminations from 2013 to 2023
29天前
已完结
A rapid chemical reprogramming system to generate human pluripotent stem cells
1个月前
已完结
Chemical reprogramming of human somatic cells to pluripotent stem cells
1个月前
已完结
GluN2A mediates ketamine-induced rapid antidepressant-like responses
3个月前
已完结
Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression
3个月前
已完结
HighPlay: Cyclic Peptide Sequence Design Based on Reinforcement Learning and Protein Structure Prediction
4个月前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
5个月前
已完结
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
5个月前
已完结
Targeted protein degradation for cancer therapy
6个月前
已完结
皖公网安备34019202002308
